Pitavastatin Calcium — next-generation statin
100 film-coated tablets × 2 mg

• Mechanism: selective HMG-CoA reductase inhibitor → lowers LDL-C & apoB, raises HDL.
• Research uses: dyslipidemia models, atherosclerosis prevention, cardio-metabolic synergy with GLP-1 agonists.
• Typical research dosing: 2 mg once daily in rodent & primate studies · 4 mg for high-risk lipid panels.
• Metabolic profile: minimal CYP450 interaction vs other statins — useful in poly-drug protocols.
• QC: ≥ 99 % API purity (HPLC); GMP tablet press; tamper-evident cap with scratch-code authenticity.